Articles tagged with “pharmacovigilance”

Analyze FDA Project Elsa, a generative AI system that prioritizes facility inspections by detecting risk patterns in adverse events and regulatory data.

Guide to AI-driven literature monitoring in pharmacovigilance. Covers NLP techniques, signal detection, and regulatory intelligence automation strategies.

Evaluate drug interaction checkers like Lexicomp and Medscape. This review compares sensitivity, clinical accuracy, and features for effective DDI screening.

Learn how AI automates adverse event detection in pharmacovigilance. This guide covers GVP compliance, NLP methods, and validation standards for safety data.

An educational guide comparing the EU Risk Management Plan (RMP) vs. the US REMS for drug safety. Learn about key differences in scope, content, and triggers.

A clear comparison of the DSUR vs. the PSUR/PBRER. Understand the distinct purpose, scope, timing, and governance of these key pharmacovigilance safety reports.

An in-depth guide to the ICH E2B(R3) standard for pharmacovigilance. Explore the data structure of ICSRs, electronic reporting rules, and key global systems.

An in-depth analysis of the top pharmacovigilance databases: Oracle Argus, ArisGlobal LifeSphere, and Veeva Vault Safety. Compare features, compliance & costs.

Learn how AI and machine learning analyze Real-World Data (RWD) to generate Real-World Evidence (RWE). Explore key applications, benefits, and challenges.

Learn the end-to-end pharmacovigilance process for translating safety signals into drug label updates. This guide explains CCDS and how Vault Signal accelerates

A guide to Reference Safety Information (RSI) in clinical trials. Learn the regulatory framework, common pitfalls, and how to avoid SUSAR reporting errors.

Explore the regulatory process for negotiating an FDA boxed warning on drug labeling, from initial NDA review to post-market Safety Labeling Changes (SLCs).

Explore a structured cascade model for rolling out pharma safety labeling updates to global affiliates, ensuring regulatory compliance and sub-90-day implementa

Learn how MedDRA and WHODrug standardize coding for adverse events and medications in clinical trials. This guide covers their structure, use, and best practice

Learn the key differences between an Adverse Event (AE), Serious AE (SAE), and SUSAR. This guide clarifies definitions, causality, and expedited reporting timel

An educational guide to leading pharmacovigilance service providers. Learn about the PV outsourcing market, regulatory drivers, and compare top drug safety CROs

An in-depth analysis of pharmaceutical compliance software for GxP and QMS. Learn key features for 21 CFR Part 11 and compare top vendors like Veeva & MasterCon

Learn about the modern pharmacovigilance tech landscape. This guide explains key systems, AI/ML for signal detection, PV automation, and data standards for drug

Get a detailed guide to Oracle Life Sciences solutions. Learn about key products for clinical trials (Clinical One) and pharmacovigilance (Argus Safety).

Updated 2026 guide to synthetic data in pharmaceutical research. Covers acceptance criteria for fidelity, utility, and privacy, plus latest FDA/EMA AI guidance, EHDS, and diffusion model advances.

Updated for 2026, this article provides a technical overview of pharmacovigilance software, detailing core functions, regulatory compliance, agentic AI developments, and a comparison of leading platforms including Oracle Argus, ArisGlobal LifeSphere, Veeva Vault Safety, and more.

An overview of AI agents in pharmacovigilance (PV), covering agentic AI, generative AI, and ML applications in safety data processing, ICSR management, and signal detection, with updates on the CIOMS WG XIV final report, FDA's Elsa tool, and EU AI Act requirements.

Learn about the FDA Adverse Event Reporting System (FAERS), now updated in real time with over 31 million reports, for post-marketing drug safety surveillance, signal detection, and AI-enhanced pharmacovigilance.

A comprehensive overview of AI in pharmacovigilance (updated Feb 2026), covering agentic AI, GenAI-driven case processing, signal detection, CIOMS WG XIV framework, FDA/EMA joint principles, EU AI Act implications, and the latest industry platforms.

Explore real-world case studies of how pharmaceutical companies are leveraging big data, AI, and cloud computing across the drug lifecycle - from discovery to marketing - with measurable outcomes and lessons learned.

Comprehensive analysis of big data technologies used in pharmaceutical industry, including Hadoop, Spark 4.x, cloud data warehouses (Snowflake, Databricks), NoSQL databases, and specialized genomics platforms, with detailed comparisons and implementation examples. Updated for 2025-2026 with latest market data and technology developments.

Comprehensive overview of Oracle's role in the pharmaceutical industry, covering their Health Sciences solutions, cloud infrastructure, compliance features, and case studies of successful implementations at major pharma companies.

A comprehensive overview of the most influential open-source software tools transforming pharmaceutical research, development, and manufacturing, from cheminformatics to clinical data management and regulatory compliance.